IP Library Granted Patent US 12,410,210
Granted Patent B2
US 12,410,210 · App. 18/616,995 · Granted Sep 9, 2025

Neuroactive steroids and their methods of use

Inventors: Maria Jesus Blanco-Pillado (Arlington, MA); Francesco G. Salituro (Marlborough, MA); Marshall Lee Morningstar (Framingham, MA)
Assignee: Sage Therapeutics, Inc.
C07J43/003C07J41/0044C07J41/0094
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,410,210
App. No.
18/616,995
Granted
Sep 9, 2025
Kind
B2
Abstract

Provided herein is a compound of Formula (I) or a pharmaceutically acceptable salt thereof, wherein R 19 , R 5 , R 3a , R 1a , R 1b , R 2a , R 2b , R 4a , R 4b , R 6a , R 6b , R 7a , R 7b , R 11a , R 11b , R 12a , R 12b , R 18 , R D , and q are defined herein. L is selected from the group consisting of: wherein A indicates the point of attachment at C17 and wherein X is selected from the group consisting of —C(O)N(R 55a )(R 55b ), —N(R 55a )(R 55b ), —N(R 55b )C(O)(R 55a ), and R 55C wherein R 55c is carbon-bound substituted or unsubstituted heteroaryl or substituted or unsubstituted aryl. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) and methods of using the compounds, e.g., in the treatment of CNS-related disorders.

Claims (62)

1. A compound selected from

Exa-

Structure

mple

305

306

317

318

325

326

 51

 52

355

and

356

2. A compound selected from

Example

Structure

305

317

325

 51

and

355

3. A compound selected from

Example

Structure

306

318

326

 52

356

4. The compound of claim 1 , wherein the compound has the structural formula

5. The compound of claim 1 , wherein the compound has the structural formula

6. The compound of claim 1 , wherein the compound has the structural formula

7. The compound of claim 1 , wherein the compound has the structural formula

8. The compound of claim 1 , wherein the compound has the structural formula

9. The compound of claim 1 , wherein the compound has the structural formula

10. The compound of claim 1 , wherein the compound has the structural formula

11. The compound of claim 1 , wherein the compound has the structural formula

12. The compound of claim 1 , wherein the compound has the structural formula

13. The compound of claim 1 , wherein the compound has the structural formula

14. A pharmaceutical composition comprising a compound having the structural formula

and a pharmaceutically acceptable excipient.

15. A pharmaceutical composition comprising a compound having the structural formula

and a pharmaceutically acceptable excipient.

16. A pharmaceutical composition comprising a compound having the structural formula

and a pharmaceutically acceptable excipient.

17. A pharmaceutical composition comprising a compound having the structural formula

and a pharmaceutically acceptable excipient.

18. A pharmaceutical composition comprising a compound having the structural formula

and a pharmaceutically acceptable excipient.

19. A pharmaceutical composition comprising a compound having the structural formula

and a pharmaceutically acceptable excipient.

20. A pharmaceutical composition comprising a compound having the structural formula

and a pharmaceutically acceptable excipient.

21. A pharmaceutical composition comprising a compound having the structural formula

and a pharmaceutically acceptable excipient.

22. A pharmaceutical composition comprising a compound having the structural formula

and a pharmaceutically acceptable excipient.

23. A pharmaceutical composition comprising a compound having the structural formula

and a pharmaceutically acceptable excipient.

Assignments (2)
CHANGE OF NAME Recorded Apr 23, 2026
From: SAGE THERAPEUTICS, INC.
To: SAGE THERAPEUTICS, LLC
Reel/Frame 075472/0569 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2024
From: BLANCO-PILLADO, MARIA JESUS; SALITURO, FRANCESCO G.; MORNINGSTAR, MARSHALL LEE
To: SAGE THERAPEUTICS, INC.
Reel/Frame 067481/0402 →